Investment23 Feb 2026, 07:22 pm
Anthem Biosciences Sanctions Additional Financial Assistance of up to Rs. 275 Crores to Subsidiary Neoanthem Lifesciences
AI Summary
Anthem Biosciences Ltd. has executed a First Amendment to the Loan Agreement dated April 15, 2024, with its wholly owned subsidiary Neoanthem Lifesciences Private Limited. The amendment allows Anthem Biosciences to convert an additional amount of up to Rs. 275,00,00,000 (Rupees Two Hundred and Seventy Five Crores Only) of the loan into equity shares of Neoanthem, within the overall sanctioned financial assistance limit of Rs. 550,00,00,000 (Rupees Five Hundred and Fifty Crores). The financial assistance is in the nature of an unsecured loan and carries interest as per the terms mutually agreed between the parties. The Company holds 100% of the equity shares of Neoanthem.
Key Highlights
- Anthem Biosciences has executed a First Amendment to the Loan Agreement with its subsidiary Neoanthem Lifesciences.
- The amendment allows Anthem Biosciences to convert an additional amount of up to Rs. 275 Crores of the loan into equity shares of Neoanthem.
- The overall sanctioned financial assistance limit is Rs. 550 Crores.
- The financial assistance is an unsecured loan with interest as per mutually agreed terms.
- Anthem Biosciences holds 100% equity shares of Neoanthem.